152 related articles for article (PubMed ID: 32412716)
1. Giant Cell Tumor of Bone With Cartilage Matrix: A Clinicopathologic Study of 17 Cases.
Brčić I; Yamani F; Inwards CY; Sumathi V; Dodd L; Kreiger PA; Sittampalam K; Allred TR; Kashofer K; Liegl-Atzwanger B; Kerr DA; Nielsen GP; Rosenberg AE
Am J Surg Pathol; 2020 Jun; 44(6):748-756. PubMed ID: 32412716
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemistry for histone H3G34W and H3K36M is highly specific for giant cell tumor of bone and chondroblastoma, respectively, in FNA and core needle biopsy.
Schaefer IM; Fletcher JA; Nielsen GP; Shih AR; Ferrone ML; Hornick JL; Qian X
Cancer Cytopathol; 2018 Aug; 126(8):552-566. PubMed ID: 29757500
[TBL] [Abstract][Full Text] [Related]
3. The two faces of giant cell tumor of bone.
Scotto di Carlo F; Whyte MP; Gianfrancesco F
Cancer Lett; 2020 Oct; 489():1-8. PubMed ID: 32502498
[TBL] [Abstract][Full Text] [Related]
4. [Clinicopathologic differential diagnosis of giant cell-rich osteosarcoma and giant cell tumor of bone].
Huang J; Jiang Z; Zhang H
Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):379-82. PubMed ID: 25208987
[TBL] [Abstract][Full Text] [Related]
5. Histologic Spectrum of Giant Cell Tumor (GCT) of Bone in Patients 18 Years of Age and Below: A Study of 63 Patients.
Al-Ibraheemi A; Inwards CY; Zreik RT; Wenger DE; Jenkins SM; Carter JM; Boland JM; Rose PS; Jin L; Oliveira AM; Fritchie KJ
Am J Surg Pathol; 2016 Dec; 40(12):1702-1712. PubMed ID: 27526293
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.
Rekhi B; Verma V; Gulia A; Jambhekar NA; Desai S; Juvekar SL; Bajpai J; Puri A
Pathol Oncol Res; 2017 Jan; 23(1):157-164. PubMed ID: 27722984
[TBL] [Abstract][Full Text] [Related]
7. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and molecular differences between giant-cell tumour of soft tissue and its bone counterpart.
Mancini I; Righi A; Gambarotti M; Picci P; Dei Tos AP; Billings SD; Simi L; Franchi A
Histopathology; 2017 Sep; 71(3):453-460. PubMed ID: 28477388
[TBL] [Abstract][Full Text] [Related]
9. Benign giant cell tumor of bone with osteosarcomatous transformation ("dedifferentiated" primary malignant GCT): report of two cases.
Brien EW; Mirra JM; Kessler S; Suen M; Ho JK; Yang WT
Skeletal Radiol; 1997 Apr; 26(4):246-55. PubMed ID: 9151375
[TBL] [Abstract][Full Text] [Related]
10. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
[TBL] [Abstract][Full Text] [Related]
11. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
[TBL] [Abstract][Full Text] [Related]
12. The identification of H3F3A mutation in giant cell tumour of the clivus and the histological diagnostic algorithm of other clival lesions permit the differential diagnosis in this location.
Scotto di Carlo F; Divisato G; Iacoangeli M; Esposito T; Gianfrancesco F
BMC Cancer; 2018 Apr; 18(1):358. PubMed ID: 29609578
[TBL] [Abstract][Full Text] [Related]
13. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls.
Roitman PD; Jauk F; Farfalli GL; Albergo JI; Aponte-Tinao LA
Hum Pathol; 2017 May; 63():89-97. PubMed ID: 28235628
[TBL] [Abstract][Full Text] [Related]
14. [Clinical studies on effect of bone cement filling on articular cartilage of the knee after curettage of giant cell tumor].
Cao W; Ye Z; Lin N; Liu M
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Dec; 28(12):1459-63. PubMed ID: 25826886
[TBL] [Abstract][Full Text] [Related]
15. Long bones giant cells tumors: treatment by curretage and cavity filling cementation.
Fraquet N; Faizon G; Rosset P; Phillipeau J-; Waast D; Gouin F
Orthop Traumatol Surg Res; 2009 Oct; 95(6):402-6. PubMed ID: 19767256
[TBL] [Abstract][Full Text] [Related]
16. The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts.
Zheng MH; Robbins P; Xu J; Huang L; Wood DJ; Papadimitriou JM
Histol Histopathol; 2001 Jan; 16(1):297-307. PubMed ID: 11193206
[TBL] [Abstract][Full Text] [Related]
17. Histone H3.3 mutation in giant cell tumor of bone: an update in pathology.
Yamamoto H; Ishihara S; Toda Y; Oda Y
Med Mol Morphol; 2020 Mar; 53(1):1-6. PubMed ID: 31748824
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical Characterization of Giant Cell Tumor of Bone Treated With Denosumab: Support for Osteoblastic Differentiation.
Kerr DA; Brcic I; Diaz-Perez JA; Shih A; Wilky BA; Pretell-Mazzini J; Subhawong TK; Nielsen GP; Rosenberg AE
Am J Surg Pathol; 2021 Jan; 45(1):93-100. PubMed ID: 32773532
[TBL] [Abstract][Full Text] [Related]
19. Proteases and interleukin-6 gene analysis in 92 giant cell tumors of bone.
Gamberi G; Benassi MS; Ragazzini P; Pazzaglia L; Ponticelli F; Ferrari C; Balladelli A; Mercuri M; Gigli M; Bertoni F; Picci P
Ann Oncol; 2004 Mar; 15(3):498-503. PubMed ID: 14998856
[TBL] [Abstract][Full Text] [Related]
20. Expression of bone morphogenetic proteins in giant cell tumor of bone.
Kudo N; Ogose A; Ariizumi T; Kawashima H; Hotta T; Hatano H; Morita T; Nagata M; Siki Y; Kawai A; Hotta Y; Hoshino M; Endo N
Anticancer Res; 2009 Jun; 29(6):2219-25. PubMed ID: 19528484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
